PILOTTO, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 10.065
AS - Asia 3.473
EU - Europa 2.417
SA - Sud America 1.013
AF - Africa 89
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 17.076
Nazione #
US - Stati Uniti d'America 9.951
SG - Singapore 1.548
BR - Brasile 864
CN - Cina 729
IT - Italia 587
HK - Hong Kong 538
SE - Svezia 386
RU - Federazione Russa 341
VN - Vietnam 261
DE - Germania 234
GB - Regno Unito 169
UA - Ucraina 158
FR - Francia 152
FI - Finlandia 124
ID - Indonesia 79
IN - India 74
NL - Olanda 69
CA - Canada 58
AR - Argentina 56
BD - Bangladesh 39
AT - Austria 37
MX - Messico 35
PL - Polonia 31
IE - Irlanda 30
TR - Turchia 30
EC - Ecuador 24
IQ - Iraq 24
BE - Belgio 23
ZA - Sudafrica 22
ES - Italia 21
JP - Giappone 21
MA - Marocco 20
SA - Arabia Saudita 18
VE - Venezuela 18
AU - Australia 14
PK - Pakistan 14
CI - Costa d'Avorio 13
CO - Colombia 12
CL - Cile 11
KE - Kenya 10
PE - Perù 10
AE - Emirati Arabi Uniti 9
TN - Tunisia 9
UZ - Uzbekistan 9
IL - Israele 8
KR - Corea 8
LT - Lituania 8
PY - Paraguay 8
TW - Taiwan 8
IR - Iran 6
JM - Giamaica 6
OM - Oman 6
RO - Romania 6
AZ - Azerbaigian 5
BG - Bulgaria 5
BO - Bolivia 5
CR - Costa Rica 5
EG - Egitto 5
JO - Giordania 5
NP - Nepal 5
SN - Senegal 5
CZ - Repubblica Ceca 4
KZ - Kazakistan 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
UY - Uruguay 4
CH - Svizzera 3
EE - Estonia 3
HR - Croazia 3
KG - Kirghizistan 3
LI - Liechtenstein 3
NO - Norvegia 3
PH - Filippine 3
PS - Palestinian Territory 3
QA - Qatar 3
RS - Serbia 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
GR - Grecia 2
GT - Guatemala 2
MY - Malesia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GY - Guiana 1
HU - Ungheria 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
PA - Panama 1
Totale 17.070
Città #
Fairfield 1.371
Ashburn 1.033
Woodbridge 921
Singapore 768
Houston 706
Chandler 659
Seattle 590
Cambridge 542
Hong Kong 526
Wilmington 451
Ann Arbor 357
Jacksonville 345
Nyköping 341
Beijing 256
Dallas 227
Lawrence 151
Roxbury 151
New York 143
Los Angeles 117
Nanjing 114
Des Moines 104
Ho Chi Minh City 82
San Diego 69
Dearborn 67
Boardman 66
Bari 62
Jakarta 60
São Paulo 57
Munich 56
Santa Clara 54
Dong Ket 53
Brooklyn 51
Hanoi 50
Milan 48
Paris 47
Princeton 43
Inglewood 40
London 40
Chicago 38
Taranto 37
Buffalo 36
Columbus 36
Rio de Janeiro 36
The Dalles 32
Nuremberg 31
Moscow 30
Dublin 29
Helsinki 28
Ostuni 28
Washington 28
San Jose 27
Redwood City 26
Council Bluffs 25
Shenyang 25
Warsaw 24
Brussels 23
Nanchang 23
Ruvo Di Puglia 22
Pune 21
Rome 21
Strasbourg 21
Porto Alegre 20
Jiaxing 18
San Francisco 17
Toronto 17
Belo Horizonte 16
Tokyo 16
Denver 15
Hebei 15
Montreal 15
Atlanta 14
Genoa 14
Vienna 14
Abidjan 13
Changsha 13
Falkenstein 13
Frankfurt am Main 13
Mexico City 13
Boston 12
Brasília 12
Falls Church 12
Manchester 12
Phoenix 12
Turin 12
Amsterdam 11
Foggia 11
Las Vegas 11
Guangzhou 10
Johannesburg 10
Juiz de Fora 10
Orem 10
Poplar 10
Quito 10
San Mateo 10
Campinas 9
Chennai 9
Curitiba 9
Fortaleza 9
Guarulhos 9
Hefei 9
Totale 11.950
Nome #
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 410
Development of a smart post-hospitalization facility for older people by using domotics, robotics, and automated tele-monitoring 225
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 184
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 183
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 174
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 173
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 170
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 163
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 154
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment 151
Paraplegia due to Anterior Spinal Artery Stroke: Rehabilitative Program on Lower Extremity Weakness and Locomotor Function 148
Addition of the Multidimensional Prognostic Index to the Estimated Glomerular Filtration Rate Improves Prediction of Long-Term All-Cause Mortality in Older Patients with Chronic Kidney Disease 147
Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment 146
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 145
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 145
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. 144
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. 143
Validation of a Brief Form of the Self-Administered Multidimensional Prognostic Index: The SELFY-BRIEF-MPI Project 141
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 141
A New Computer-Based Tool to Reduce Potentially Inappropriate Prescriptions in Hospitalized Geriatric Patients 140
Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: A systematic review and meta-analysis 138
A multidimensional approach to frailty in older people 134
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes 132
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 131
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 131
The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI) 131
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment. 129
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease 129
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 128
. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging 128
Klotho Gene and Selective Serotonin Reuptake Inhibitors: Response to Treatment in Late-Life Major Depressive Disorder 128
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 127
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 127
Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia 125
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 125
Vascular risk factors, alcohol intake, and cognitive decline 125
Robotic balance assessment in community-dwelling older people with different grades of impairment of physical performance 125
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 124
Cognitive frailty: Predementia syndrome and vascular risk factors 123
Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy 123
Peripheral Antioxidant Markers in Mild Cognitive Impairment and its Progression to Dementia 123
Nutrition, frailty, and Alzheimer's disease. 122
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 121
Apolipoprotein E Genotypes in Hospitalized Elderly Patients with Vascular Dementia 118
Dietary unsaturated fatty acids and risk of mild cognitive impairment 118
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 118
Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease 117
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques 117
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 115
Dietary fatty acids, age-related cognitive decline and mild cognitive impairment 114
Agreement of a short form of the self-administered multidimensional prognostic index (SELFY-MPI-SF): A useful tool for the self-assessment of frailty in community-dwelling older people 114
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 113
Association Between Gait Speed With Mortality, Cardiovascular Disease and Cancer: A Systematic Review and Meta-analysis of Prospective Cohort Studies 113
Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages 112
Enteral tube feeding and mortality in hospitalized older patients: A multicenter longitudinal study 111
The Multidimensional Prognostic Index in general practice: One-year follow-up study 111
Robot-based assessment of sitting and standing balance: Preliminary results in Parkinson's disease 110
Association Analysis of GRIN2B, Encoding N-Methyl-D-Aspartate Receptor 2B Subunit, and Alzheimer's Disease 106
. Mediterranean diet in predementia and dementia syndromes.REview 106
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. 103
Frailty and the gut 103
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease 103
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 102
Diet and Alzheimer's disease risk factors or prevention: the current evidence 102
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging. 102
Current epidemiological approaches to the metabolic-cognitive syndrome. 101
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia 101
Apolipoprotein E, dementia, and human longevity 100
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. 99
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease 99
Management of beta-thalassemia-associated osteoporosis 99
Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease 99
Apolipoprotein E-related all-cause mortality in hospitalized elderly patients 98
Three Decades of Comprehensive Geriatric Assessment: Evidence Coming From Different Healthcare Settings and Specific Clinical Conditions 98
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2) 98
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study 98
The prognostic significance of geriatric syndromes and resources 98
Mediterranean diet in predementia and dementia syndromes 97
Different models of frailty in predementia and dementia syndromes. 97
Dietary patterns and protection against Alzheimer disease and cognitive decline 96
Can information on functional and cognitive status improve short-term mortality risk prediction among community-dwelling older people? A cohort study using a UK primary care database 96
Lipoproteins, vascular-related genetic factors, and human longevity 95
A multidimensional approach to older patients during COVID-19 pandemic: a position paper of the Special Interest Group on Comprehensive Geriatric Assessment of the European Geriatric Medicine Society (EuGMS) 94
Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? 94
APOE and Alzheimer disease: a major gene with semi-dominant inheritance 94
The Multidimensional Prognostic Index Predicts in-hospital length of stay in older patients: A multicentre prospective study 94
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patients 94
Higher total cholesterol, cognitive decline, and dementia 93
Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease 93
Comprehensive Geriatric Assessment 93
Reply to Letter to the Editor “Polypharmacy in elderly people with diabetes admitted to hospital” 93
Apolipoprotein E genotypes in mild cognitive impairment subtypes 92
Urological-Geriatric Integrated Diagnostic-Therapeutic Pathway for elderly patients with urologic diseases 92
Comprehensive Geriatric Assessment in the Hospital 91
Evaluation design of effichronic: The chronic disease self-management programme (CDSMP) intervention for citizens with a low socioeconomic position 91
Cerebral vasoreactivity and intima-media thickness in Down syndrome: A case-control study 91
Oral health indicators and bone mineral density disorders in older age: A systematic review 90
Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages 90
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease 90
Effects of oral amino acid supplementation on Multidimensional Prognostic Index in hospitalized older patients: a multicenter randomized, double-blind, placebo-controlled pilot study 90
Totale 12.112
Categoria #
all - tutte 73.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.375


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.231 0 0 0 0 0 166 266 174 109 273 102 141
2021/20221.026 46 65 7 29 60 107 50 46 78 78 164 296
2022/20231.805 246 172 126 157 170 232 33 246 287 22 76 38
2023/2024703 57 105 53 49 54 173 27 46 21 33 17 68
2024/20253.291 83 57 262 142 91 248 357 260 177 201 488 925
2025/20263.777 956 346 546 815 768 346 0 0 0 0 0 0
Totale 17.629